Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit

Gut. 2020 Aug;69(8):1377-1378. doi: 10.1136/gutjnl-2019-320355. Epub 2020 Mar 23.
No abstract available

Keywords: biliary cirrhosis; health economics; primary biliary cirrhosis.

Publication types

  • Comment

MeSH terms

  • Cholagogues and Choleretics / therapeutic use
  • Cholangitis* / drug therapy
  • Cholangitis* / prevention & control
  • Humans
  • Liver Cirrhosis, Biliary* / drug therapy
  • Liver Transplantation*
  • Ursodeoxycholic Acid / therapeutic use

Substances

  • Cholagogues and Choleretics
  • Ursodeoxycholic Acid